J Clin Pharmacol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Sign In to gain access to subscriptions and/or personal tools.
The Journal of Clinical Pharmacology, 1974; 14:329-338
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wagner, J. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wagner, J. G.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Loading and Maintenance Doses of Digoxin in Patients with Normal Renal Function and Those with Severely Impaired Renal Function

John G. Wagner Ph.D.1

1 College of Pharmacy and the Upjohn Center for Clinical Pharmacology, The University of Michigan, Ann Arbor, Mich. 48104.

Pharmacokinetic analysis indicates that patients with severely impaired renal function should receive the same loading dose of digoxin as patients with normal renal function. The calculated loading dose for both types of patients, however, is appreciably lower than the usually recommended loading doses in the literature. The analysis has indicated that the patients with severely impaired renal function should be administered maintenance doses of digoxin which are only about one half those administered to patients with normal renal function. Under these conditions, both types of patients will have equal average amounts of digoxin in the body (and in compartment 2 of the two-compartment open model) at the steady state. To achieve equal average steady state plasma concentrations, the maintenance dose of the patients with severely impaired renal function would have to be one third of the maintenance dose administered to patients with normal renal function; the loading dose would have to be about five times the maintenance dose for the severely impaired renal patients, and about two and a half times the maintenance dose for the patients with normal renal function. Thus, using the plasma concentration criterion, the loading dose in patients with severely impaired renal function would be two thirds of the loading for patients with normal renal function, since 5.0*0.33/2.5*1 = 1.65/2.5bsime0.67.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
ANN INTERN MEDHome page
W. M. BENNETT, R. S. MUTHER, R. A. PARKER, P. FEIG, G. MORRISON, T. A. GOLPER, and I. SINGER
Drug Therapy in Renal Failure: Dosing Guidelines for Adults: Part II: Sedatives, Hypnotics, and Tranquilizers; Cardiovascular, Antihypertensive, and Diuretic Agents; Miscellaneous Agents
Ann Intern Med, August 1, 1980; 93(2): 286 - 325.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
W. M. BENNETT, I. SINGER, T. GOLPER, P. FEIG, and C. J. COGGINS
Guidelines for Drug Therapy in Renal Failure
Ann Intern Med, June 1, 1977; 86(6): 754 - 783.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1974 by the American College of Clinical Pharmacology